ACCENDRA HEALTH INC VA (ACH)
ACCENDRA HEALTH INC VA (ACH)
| Cash Flow | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Net loss | -6,468 | -1,100,642 |
| Net revenue | - | 7,909,655 |
| Cost of goods sold | - | 7,125,144 |
| Gross profit | - | 784,511 |
| Distribution, selling, and administrative expenses | - | 782,789 |
| Acquisition-related charges and intangible amortization | - | 12,549 |
| Exit and realignment charges, net | - | 72,379 |
| Goodwill impairment charge | - | 106,389 |
| Loss on classification to held for sale | - | 798,934 |
| Other operating expense, net | - | -10,932 |
| Operating (loss) income | - | -999,461 |
| Interest expense, net | - | -36,001 |
| Other expense | - | 1,405 |
| Loss from discontinued operations before income taxes | - | -1,036,867 |
| Income tax benefit for discontinued operations | - | -38,907 |
| Loss from discontinued operations, net of tax | 0 | -997,960 |
| Depreciation and amortization | 61,742 | 214,524 |
| Share-based compensation expense | 3,090 | 12,873 |
| Deferred income tax expense (benefit) | 2,571 | -17,887 |
| Changes in operating lease right-of-use assets and lease liabilities | -122 | -735 |
| Gain from sale and dispositions of patient service equipment | 55,509 | 27,274 |
| Accounts receivable, net | 7,796 | -122,363 |
| Inventories, net | -9,150 | 6,854 |
| Accounts payable | 8,775 | 6,478 |
| Net change in other assets and liabilities | 69,174 | 56,779 |
| Other, net | -3,420 | -8,999 |
| Cash used for operating activities from discontinued operations | 0 | -256,286 |
| Cash used for operating activities | -50,077 | -101,790 |
| Proceeds from p&hs sale | - | 342,351 |
| Cash sold with p&hs sale | - | 18,091 |
| Additions to patient service equipment (41,343 and 44,484) and other fixed assets | 41,646 | 190,956 |
| Proceeds from sale of patient service equipment | 96,415 | 77,968 |
| Additions to computer software | 844 | 10,369 |
| Other, net | 0 | 1,910 |
| Cash used for investing activities from discontinued operations | 0 | -54,570 |
| Cash provided by (used for) investing activities | 53,925 | 144,423 |
| Borrowings under revolving credit facility | 269,100 | 2,914,784 |
| Repayments under revolving credit facility | 217,600 | 2,711,284 |
| Repurchase of common stock | 0 | 10,179 |
| Other, net | -416 | -3,116 |
| Cash used for financing activities from discontinued operations | 0 | -2,127 |
| Cash provided by financing activities | 51,084 | 188,078 |
| Effect of exchange rate changes on cash and cash equivalents | -41 | 1,896 |
| Net increase in cash and cash equivalents | 54,891 | 232,607 |
| Statement table | - | 0 |
| Cash, cash equivalents and restricted cash at end of period | - | 0 |
| Cash and cash equivalents at beginning of period | 281,989 | 49,382 |
| Cash and cash equivalents at end of period | 336,880 | 281,989 |